ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 13 (3) 839 -849     DOI: 10.1677/erc.1.01190
Copyright © 2006 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fritzsche, S
Right arrow Articles by Schulz, W A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fritzsche, S
Right arrow Articles by Schulz, W A

Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma

S Fritzsche, M Kenzelmann1, M J Hoffmann, M Müller, R Engers2, H-J Gröne1 and W A Schulz

Department of Urology, Heinrich-Heine University, Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany
1 Department of Cellular and Molecular Pathology, German Cancer Research Centre, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
2 Department of Pathology, Heinrich-Heine University, Düsseldorf, Germany

(Requests for offprints should be addressed to W A Schulz; Email: wolfgang.schulz{at}uni-duesseldorf.de)

Sprouty proteins encoded by the SPRY genes act as modulators and feedback inhibitors of signalling by epidermal growth factor (EGF) and fibroblast growth factor (FGF). Overactivity of EGF and FGF signalling common in prostate cancer might therefore be exacerbated by Sprouty down-regulation. Indeed, down-regulation of SPRY1 and SPRY2 expression has been independently reported. We found both genes modestly down-regulated by microarray expression analysis of microdissected prostate cancers and by quantitative RT-PCR in macrodissected specimens compared with benign tissues. Importantly, the decreases paralleled each other and expression levels of both genes were significantly lower in cancers that recurred within the average follow-up period of 32 months. In contrast to a previous report, no hypermethylation was found to accompany down-regulation of SPRY2 in cancer tissues and cell lines. We additionally investigated the expression of an SPRY1 alternative transcript presumed to be specific for fetal tissues and found its expression moderately well correlated with expression of the standard transcript through diverse tissues and cell lines. The present study confirms and extends previous reports by demonstrating concomitant down-regulation and a significant association with recurrence of SPRY genes.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
F. Edwin, K. Anderson, C. Ying, and T. B. Patel
Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease
Mol. Pharmacol., October 1, 2009; 76(4): 679 - 691.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. C. Brady, M. L. Coleman, J. Munro, S. M. Feller, N. A. Morrice, and M. F. Olson
Sprouty2 Association with B-Raf Is Regulated by Phosphorylation and Kinase Conformation
Cancer Res., September 1, 2009; 69(17): 6773 - 6781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. J. Frank, D. W. Dawson, S. J. Bensinger, J. S. Hong, W. M. Knosp, L. Xu, C. E. Balatoni, E. L. Allen, R. R. Shen, D. Bar-Sagi, et al.
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
Blood, March 12, 2009; 113(11): 2478 - 2487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lito, B. D. Mets, S. Kleff, S. O'Reilly, V. M. Maher, and J. J. McCormick
Evidence That Sprouty 2 Is Necessary for Sarcoma Formation by H-Ras Oncogene-transformed Human Fibroblasts
J. Biol. Chem., January 25, 2008; 283(4): 2002 - 2009.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.